Stocks
Apollomics, Inc.APLM
NASDAQHealthcareBiotechnology$22.05
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted oncology therapies, including small molecules and antibody-drug conjugates. Its lead candidates address solid tumors with high unmet medical need, and investors track the stock for its pipeline milestones and regulatory catalysts.
52W Range: $10.01-$33.09
Congressional Interest in Apollomics, Inc. (APLM)
No congressional trades have been disclosed for Apollomics, Inc. (APLM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading APLM?
No congressional trades found for this stock.